First International Bank & Trust Merck & Co., Inc. Transaction History

First International Bank & Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$102.95 - $114.33 $217,121 - $241,121	-2,109 Reduced 41.28%	3,000 $308,000
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $4,018 - $4,380	37 Added 0.73%	5,109 $589,000
Q1 2023 Apr 14, 2023	SELL	$102.94 - $114.86 $21,823 - $24,350	-212 Reduced 4.01%	5,072 $539,000
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $85,516 - $109,643	-978 Reduced 15.62%	5,284 $586,000
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $73,963 - $83,090	875 Added 16.24%	6,262 $539,000
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $69,213 - $78,456	829 Added 18.19%	5,387 $491,000
Q1 2022 Apr 08, 2022	BUY	$73.51 - $82.4 $23,596 - $26,450	321 Added 7.58%	4,558 $374,000
Q4 2021 Mar 29, 2022	BUY	$72.28 - $90.54 $306,250 - $383,617	4,237 New	4,237 $325,000

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of First International Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First International Bank & Trust with notifications on news.